Gardasil side-effects very, very minor, says AMA

Gardasil

Australian Medical Association asserts that the benefits of the anti-cervical cancer drug called Gardasil by far outweigh the risks listed out by a new report.

More than 12,000 women in the United States suffered adverse effects after taking the vaccine and 32 women died after receiving Gardasil, says the report in the Journal of the American Medical Association.

The report also rules out the vaccine being specifically related to the deaths. Some general side-effects were dizziness, fainting and headaches but some severe ones were noted in the U. S. including blood clots and auto-immune diseases.

These conditions were noticed after more than 23 million doses were administered in the U. S. from 2006-2008. Millions of such doses have been dispensed at no charge to Australian females between ages 12 to 26.

AMA president Andrew Pesce said his daughters had been administered Gardasil and he supported the ongoing vaccination program.

"What I'd be saying is that when you have a vaccine you may sometimes get some adverse effects, and fortunately, by far and away, those adverse effects are very, very minor " Dr Pesce said. He strongly recommended the vaccine to all women and held the view that cervical cancer is a terrible disease and a major cause of death in the female population.

A range of strains of the human papillomavirous causing almost 70 percent of cervical cancers in women, can be prevented by Gardasil, which was jointly developed in Australian and U. S. laboratories.

Latest News

Microsoft Might Support Third-Party USB Storage for Xbox 360 Console
California Median Home Price Registers a Rise in Feb.
FDIC Chief Shows Concern for Senate Reform Bill
Universal Music Looking to "Bring New Life" to Flagging Format by Pulling Down C
EADS Consider To Rejoin the Bid for U.S. Tanker if Conditions are Met
Best Buy Upgraded to "Buy" by Goldman
Energy Policy Plans Launched by UK Conservatives
FDA Disapproves AP Pharma Nausea Drug
African Barrick Gold to Raise £581 Million in an IPO
Finnish Port Workers Agree to End Strike
Asian Bond Market Cherishes Investors
China Debarred Form Australia's Access to Rio Trial